Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
China flag China · Delayed Price · Currency is CNY
3.770
-0.010 (-0.27%)
Jun 20, 2025, 2:45 PM CST

Guizhou Yibai Pharmaceutical Company Description

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China.

It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, analgesic, cancer, orthopedics, digestion, andrology, and urology.

The company also engages in investment in the cultivation and breeding projects of medicinal materials; and agricultural products sale, as well as provides market information consulting services for medicinal materials; and research and development, and information consulting services for health food.

Guizhou Yibai Pharmaceutical Co., Ltd. was founded in 1995 and is headquartered in Guiyang, China.

Guizhou Yibai Pharmaceutical Co., Ltd.
Country China
Founded 1995
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 5,261
CEO Ya Qi Dou

Contact Details

Address:
No. 220-1, Baiyun Avenue
Guiyang, 550008
China
Phone 86 85 1847 05590
Website gzcci.com

Stock Details

Ticker Symbol 600594
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE000001H03
SIC Code 2834

Key Executives

Name Position
Ya Qi Dou GM and Vice Chairman
Zhiwei Wang CPA Executive Deputy GM and Director